• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

导管原位癌背景下乳腺磁共振成像的进展

Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.

作者信息

Amornsiripanitch Nita, Lam Diana L, Rahbar Habib

机构信息

University of Massachusetts Memorial Medical Center, Worcester, MA.

University of Washington, Seattle Cancer Care Alliance, Seattle, WA.

出版信息

Semin Roentgenol. 2018 Oct;53(4):261-269. doi: 10.1053/j.ro.2018.08.006. Epub 2018 Aug 30.

DOI:10.1053/j.ro.2018.08.006
PMID:30449344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6537897/
Abstract

Ductal carcinoma in situ (DCIS) of the breast is a pre-invasive breast malignancy with controversial clinical relevance and management. These lesions have increased in incidence with breast cancer screening programs and are associated with increasingly recognized clinical issues of overdiagnosis and overtreatment. This article discusses the imaging presentation of these lesions with emphasis on advances in breast MRI and its role in the management of DCIS.

摘要

乳腺导管原位癌（DCIS）是一种乳腺浸润前恶性肿瘤，其临床相关性和管理存在争议。随着乳腺癌筛查项目的开展，这些病变的发病率有所上升，并与越来越多被认识到的过度诊断和过度治疗等临床问题相关。本文讨论这些病变的影像学表现，重点是乳腺磁共振成像（MRI）的进展及其在DCIS管理中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/6ef96c8db317/nihms-1022594-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/743c8148ca61/nihms-1022594-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/407fa36f0ec7/nihms-1022594-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/b709fc8ae4ef/nihms-1022594-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/6696d4a3eeb7/nihms-1022594-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/00f114f68222/nihms-1022594-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/6ef96c8db317/nihms-1022594-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/743c8148ca61/nihms-1022594-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/407fa36f0ec7/nihms-1022594-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/b709fc8ae4ef/nihms-1022594-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/6696d4a3eeb7/nihms-1022594-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/00f114f68222/nihms-1022594-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f22/6537897/6ef96c8db317/nihms-1022594-f0006.jpg

相似文献

1
Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.导管原位癌背景下乳腺磁共振成像的进展
Semin Roentgenol. 2018 Oct;53(4):261-269. doi: 10.1053/j.ro.2018.08.006. Epub 2018 Aug 30.
2
Ductal carcinoma in situ and breast MRI.导管原位癌与乳腺磁共振成像
Lancet. 2007 Aug 11;370(9586):459-60. doi: 10.1016/S0140-6736(07)61207-0.
3
Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).乳腺影像报告和数据系统（BI-RADS®）磁共振成像（MRI）在乳腺导管原位癌（DCIS）检测中的预测价值。
Eur J Radiol. 2016 Oct;85(10):1701-1707. doi: 10.1016/j.ejrad.2016.07.010. Epub 2016 Jul 19.
4
Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.老年原位导管癌女性患者术前乳腺磁共振成像与对侧乳腺癌的发生情况
Breast Cancer Res Treat. 2016 Jul;158(1):139-148. doi: 10.1007/s10549-016-3858-0. Epub 2016 Jun 10.
5
Prediction Model For Extensive Ductal Carcinoma In Situ Around Early-Stage Invasive Breast Cancer.早期浸润性乳腺癌周围广泛导管原位癌的预测模型
Invest Radiol. 2016 Jul;51(7):462-8. doi: 10.1097/RLI.0000000000000255.
6
Pre-operative MRI in patients with ductal carcinoma in situ: the ongoing debate.导管原位癌患者的术前磁共振成像：持续的争论。
Eur Radiol. 2024 Jun;34(6):3967-3969. doi: 10.1007/s00330-023-10460-2. Epub 2023 Nov 24.
7
Comparison of mammography, ultrasound, and MRI in size assessment of ductal carcinoma in situ with histopathologic correlation.乳腺钼靶、超声及磁共振成像在导管原位癌大小评估中的比较及其与组织病理学的相关性
Acta Radiol. 2017 Dec;58(12):1434-1441. doi: 10.1177/0284185117698860. Epub 2017 Mar 10.
8
Sensitivity of breast MRI for ductal carcinoma in situ appearing as microcalcifications only on mammography.乳腺磁共振成像（MRI）对仅在乳腺钼靶上表现为微钙化的导管原位癌的敏感性。
Clin Imaging. 2016 Nov-Dec;40(6):1207-1212. doi: 10.1016/j.clinimag.2016.08.001. Epub 2016 Aug 6.
9
Ductal Carcinoma in situ Detected during Prospective MR Imaging Screening of a Woman with a BRCA2 Mutation: The First Case Report in Japan.在对一名携带BRCA2突变的女性进行前瞻性磁共振成像筛查期间检测到导管原位癌：日本首例病例报告
Magn Reson Med Sci. 2017 Jul 10;16(3):265-269. doi: 10.2463/mrms.cr.2016-0090. Epub 2017 Jan 13.
10
The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.动态对比增强磁共振成像和乳腺特异性γ成像对伴有钙化和非钙化导管原位癌女性的诊断敏感性
Acta Radiol. 2014 Jul;55(6):668-75. doi: 10.1177/0284185113505086. Epub 2013 Sep 16.

引用本文的文献

1
Role of MRI in the Diagnosis of Ductal Carcinoma In Situ: A Retrospective Study.磁共振成像在导管原位癌诊断中的作用：一项回顾性研究。
J Clin Med. 2025 Apr 20;14(8):2842. doi: 10.3390/jcm14082842.
2
Prognostic Molecular Biomarkers in Breast Cancer Lesions with Non-Mass Enhancement on MR.磁共振成像上非肿块强化的乳腺癌病变中的预后分子生物标志物
Diagnostics (Basel). 2024 Mar 30;14(7):747. doi: 10.3390/diagnostics14070747.
3
Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis.乳腺磁共振成像：乳腺癌诊断中的临床适应症、建议及未来应用

本文引用的文献

1
Breast ductal carcinoma in situ in an unscreened population: presentation, diagnosis and management at a single tertiary centre.未筛查人群中的乳腺导管原位癌：单中心三级医疗机构的临床表现、诊断与管理
S Afr J Surg. 2017 Mar;55(1):4-9.
2
Contralateral Breast Cancer Risk in Women with Ductal Carcinoma In Situ: Is it High Enough to Justify Bilateral Mastectomy?导管原位癌患者的对侧乳腺癌风险：是否高到足以支持双侧乳房切除术？
Ann Surg Oncol. 2017 Oct;24(10):2889-2897. doi: 10.1245/s10434-017-5931-2. Epub 2017 Aug 1.
3
MR Imaging for Diagnosis of Malignancy in Mammographic Microcalcifications: A Systematic Review and Meta-Analysis.
Curr Oncol Rep. 2023 Apr;25(4):257-267. doi: 10.1007/s11912-023-01372-x. Epub 2023 Feb 7.
4
Comparison of the Magnetic Resonance Imaging Findings of Paget's Disease of the Breast and Malignant Tumor Invasion of the Nipple-Areola Complex.乳腺佩吉特病与乳头乳晕复合体恶性肿瘤侵犯的磁共振成像表现比较。
Eur J Breast Health. 2021 Jun 24;17(3):265-273. doi: 10.4274/ejbh.galenos.2021.6091. eCollection 2021 Jul.
磁共振成像在乳腺微钙化良恶性诊断中的应用：系统评价和荟萃分析。
Radiology. 2017 Jun;283(3):692-701. doi: 10.1148/radiol.2016161106. Epub 2016 Oct 27.
4
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.浸润性乳腺癌，2016年第1版，美国国立综合癌症网络（NCCN）肿瘤学临床实践指南
J Natl Compr Canc Netw. 2016 Mar;14(3):324-54. doi: 10.6004/jnccn.2016.0037.
5
Cancer statistics: Breast cancer in situ.癌症统计数据：原位乳腺癌。
CA Cancer J Clin. 2015 Nov-Dec;65(6):481-95. doi: 10.3322/caac.21321. Epub 2015 Oct 2.
6
Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?3T磁共振成像生物标志物能否识别低风险导管原位癌？
Clin Imaging. 2016 Jan-Feb;40(1):125-9. doi: 10.1016/j.clinimag.2015.07.026. Epub 2015 Jul 26.
7
Rethinking the Standard for Ductal Carcinoma In Situ Treatment.重新思考导管原位癌的治疗标准
JAMA Oncol. 2015 Oct;1(7):881-3. doi: 10.1001/jamaoncol.2015.2607.
8
Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?磁共振成像中背景实质强化、纤维腺体量的定性评估以及乳腺X线密度与乳腺癌风险相关吗？
Radiology. 2015 Aug;276(2):371-80. doi: 10.1148/radiol.2015142304. Epub 2015 May 12.
9
Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.动态对比增强磁共振成像参数作为人类乳腺癌血管生成和增殖的成像标志物
Med Sci Monit. 2015 Feb 1;21:376-82. doi: 10.12659/MSM.892534.
10
Accuracy of 3 T versus 1.5 T breast MRI for pre-operative assessment of extent of disease in newly diagnosed DCIS.3T与1.5T乳腺MRI对新诊断导管原位癌（DCIS）疾病范围术前评估的准确性
Eur J Radiol. 2015 Apr;84(4):611-6. doi: 10.1016/j.ejrad.2014.12.029. Epub 2015 Jan 8.